Formatech Donates Manufacturing Services to Produce Experimental Drug for the Treatment of Multiple Sclerosis

April 30, 2010

ANDOVER, Mass.--(BUSINESS WIRE)--Today, Formatech, Inc. announces the selection of RegeneRx Biopharmaceuticals, Inc.’s therapeutic product candidate RGN-352 as the next Fillanthropy™ Program candidate. Under this program, Formatech will donate the services required to aseptically fill and finish one lot of the drug candidate for use in clinical trials.

RGN-352 is an injectable formulation of a novel therapeutic peptide known as Thymosin Beta 4, or Tβ4, for systemic delivery to treat cardiovascular diseases, central nervous system diseases and other medical indications that can be treated by systemic administration. Recent preclinical research showed that Tβ4 significantly improved neurologic functional recovery in mice with experimental autoimmune encephalomyelitis, or EAE. This model is widely used for the study of multiple sclerosis, or MS. A debilitating disease with currently no cure, MS affects approximately 2.5 million persons worldwide. Based on the preclinical research, RegeneRx intends to supply RGN-352 in support of a Phase 1/2 clinical trial to evaluate its potential to treat patients with MS, which is proposed to be conducted at a major U.S. medical center under a physician-sponsored investigational new drug application.

“We are grateful that we can to contribute our services in an effort to find a new treatment for those afflicted with MS,” said Jeffrey Bernard, Director of Business Development at Formatech. “We are hopeful that RGN-352 will improve the quality of life for those suffering from this disease.”

About the Fillanthropy Program

Each month, Formatech will select a company to donate the services required to aseptically fill and finish one lot of drug product entering human clinical trials. We consider both the product’s potential therapeutic benefit and the financial need of the applicant. To apply, companies are encouraged to contact Jeffrey Bernard at 978-725-9077 x3164 or

About Formatech

Formatech is a contract service provider that delivers unique solutions to bio/pharmaceutical product development and manufacturing challenges. To learn more about the company and its services, visit

Formatech’s mission is to “Help make new drugs happen at the speed of science.”


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.